Medindia » Press Release » Drug News

Drug News

Email Email RSS Feeds RSS Save this page Save Link Link Syndicate Syndicate Comments Comments
Total No. of Records -2763 Page - 1 of 277 
 
LipiGesic® M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications
PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced the results of clinical trials that foun...
First Aid Shot Therapy®, Inc. ("F.A.S.T.") Completes Series A Financing Round
Consumer Healthcare Company Focused on Over-the-Counter (OTC) Therapies in Liquid 'Shot' Form to Launch First Products in U.S. in Summer 2013 First Aid Shot Therapy®, Inc. ("F.A.S.T."), a c...
Avion Pharmaceuticals, LLC., launches Prenate Chewable™, the newest addition to the Prenate® Prenatal Vitamin Family
Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of Prenate Chewable™, a chewable, chocolate-flavored version of the original Prenate® prescription pr...
Diclegis® Now Available Nationwide To Treat Pregnant Women With Nausea And Vomiting Of Pregnancy (NVP)
Prescription Treatment Now Available in Pharmacies for Nearly Three Million Pregnant Women Who Suffer From NVP Duchesnay USA, the first pharmaceutical company dedicated to the health of pre...
U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015
Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions U.S. spending on specialty prescription drugs — those ...
Trigemina to Present at the 13th Annual Pain Therapeutics Conference in London
Chief Scientist Will Also Be Presenting at 4th International Congress on Neuropathic Pain in Toronto Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of...
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases Sangamo BioSciences, Inc. (Nasda...
German Federal Joint Committee (G-BA) Issues Final Assessment Report for PIXUVRI® (pixantrone)
- Pricing Negotiations to Begin in June - Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that Germany's Federal Joint Committee (G-BA) has issued its final benefit asse...
Transition to Propellant-Free Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray Nears Completion
Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray will become the only available short-acting bronchodilator offering two different medicines in a single inhaler As ...
Mylan Launches Generic Tricor® Tablets
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval ...
Page 1 of 277
<< Top
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
Last >>
Latest Drug News
Common Drug for Depression Reduces Stress-related Heart Condition
Researchers at Duke Medicine have found that a drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease.

Compared with those receiving placebo, people who...

Read More

New, Effective Sleeping Pill from Merck to Hit US Markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall asleep and stay asleep, say reviewers at the US Food and Drug Administration, which could soon approve the new drug.

But the experts warned of da...

Read More

EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk
The benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins, said Europe's medicines watchdog.

The clot risk was "low", said a European Medicines Agency (EMA)...

Read More

Reduce Ambien's Dose to Avoid Drowsy Driving
U.S. Food and Drug Administration has now given the nod for new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) with a view to reducing daytime drowsiness. Daytime drowsiness poses a problem while doing tough tasks like driving.

Read More

Statins Cut Exercise Benefits
Simvastatin a type of statin was found to hinder the positive effects of exercise for obese and overweight adults.

Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart dise...

Read More

More Drug News
 
Free News Widget
Customize it to your web-page
Download
Press Release Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Press Release Archive
Date :
Category :
Keyword :